Study on Inotuzumab Ozogamicin for Treating B-cell Acute Lymphocytic Leukemia with Minimal Residual Disease | Clinical Trial

Study on Inotuzumab Ozogamicin for Treating B-cell Acute Lymphocytic Leukemia with Minimal Residual Disease | Clinical Trial | Right2Hope